Exosomal microRNAs as tumor markers in epithelial ovarian cancer

被引:163
作者
Pan, Chi [1 ]
Stevic, Ines [1 ]
Mueller, Volkmar [2 ]
Ni, Qingtao [1 ]
Oliveira-Ferrer, Leticia [2 ]
Pantel, Klaus [1 ]
Schwarzenbach, Heidi [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Martinistr 52, D-20246 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, Hamburg, Germany
关键词
apoptosis; cell proliferation; epithelial ovarian cancer; exosomes; ovarian cystadenoma; prognosis; CLINICAL-RELEVANCE; BIOMARKERS; BIOGENESIS; MIR-16; MIRNAS; METASTASIS; EXPRESSION; CARCINOMA; MIR-200B; INVASION;
D O I
10.1002/1878-0261.12371
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Specific microRNAs (miRNAs) are packaged in exosomes that regulate processes in tumor development and progression. The current study focuses on the influence of exosomal miRNAs in the pathogenesis of epithelial ovarian cancer (EOC). MiRNA profiles were determined in exosomes from plasma of 106 EOC patients, eight ovarian cystadenoma patients, and 29 healthy women by TaqMan real-time PCR-based miRNA array cards containing 48 different miRNAs. In cell culture experiments, the impact of miR-200b and miR-320 was determined on proliferation and apoptosis of ovarian cancer cell lines. We report that miR-21 (P = 0.0001), miR-100 (P = 0.034), miR-200b (P = 0.008), and miR-320 (P = 0.034) are significantly enriched, whereas miR-16 (P = 0.009), miR-93 (P = 0.014), miR-126 (P = 0.012), and miR-223 (P = 0.029) are underrepresented in exosomes from plasma of EOC patients as compared to those of healthy women. The levels of exosomal miR-23a (P = 0.009, 0.008) and miR-92a (P = 009, 0.034) were lower in ovarian cystadenoma patients than in EOC patients and healthy women, respectively. The exosomal levels of miR-200b correlated with the tumor marker CA125 (P = 0.002) and patient overall survival (P = 0.019). MiR-200b influenced cell proliferation (P = 0.0001) and apoptosis (P < 0.008). Our findings reveal specific exosomal miRNA patterns in EOC and ovarian cystadenoma patients, which are indicative of a role of these miRNAs in the pathogenesis of EOC.
引用
收藏
页码:1935 / 1948
页数:14
相关论文
共 42 条
[1]   Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review [J].
Azmi, Asfar S. ;
Bao, Bin ;
Sarkar, Fazlul H. .
CANCER AND METASTASIS REVIEWS, 2013, 32 (3-4) :623-642
[2]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[3]   A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells [J].
Burk, Ulrike ;
Schubert, Joerg ;
Wellner, Ulrich ;
Schmalhofer, Otto ;
Vincan, Elizabeth ;
Spaderna, Simone ;
Brabletz, Thomas .
EMBO REPORTS, 2008, 9 (06) :582-589
[4]   Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529
[5]   RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression [J].
Chen, Xi ;
Chen, Shuo ;
Xiu, Yin-Ling ;
Sun, Kai-Xuan ;
Zong, Zhi-Hong ;
Zhao, Yang .
MOLECULAR CANCER, 2015, 14
[6]   Horizontal transfer of microRNAs: molecular mechanisms and clinical applications [J].
Chen, Xi ;
Liang, Hongwei ;
Zhang, Junfeng ;
Zen, Ke ;
Zhang, Chen-Yu .
PROTEIN & CELL, 2012, 3 (01) :28-37
[7]   Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis [J].
Cheng, AM ;
Byrom, MW ;
Shelton, J ;
Ford, LP .
NUCLEIC ACIDS RESEARCH, 2005, 33 (04) :1290-1297
[8]   Transcription Factor-MicroRNA-Target Gene Networks Associated with Ovarian Cancer Survival and Recurrence [J].
Delfino, Kristin R. ;
Rodriguez-Zas, Sandra L. .
PLOS ONE, 2013, 8 (03)
[9]   Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis [J].
Ell, Brian ;
Mercatali, Laura ;
Ibrahim, Toni ;
Campbell, Neil ;
Schwarzenbach, Heidi ;
Pantel, Klaus ;
Amadori, Dino ;
Kang, Yibin .
CANCER CELL, 2013, 24 (04) :542-556
[10]   MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress [J].
Felder, Mildred ;
Kapur, Arvinder ;
Gonzalez-Bosquet, Jesus ;
Horibata, Sachi ;
Heintz, Joseph ;
Albrecht, Ralph ;
Fass, Lucas ;
Kaur, Justanjyot ;
Hu, Kevin ;
Shojaei, Hadi ;
Whelan, Rebecca J. ;
Patankar, Manish S. .
MOLECULAR CANCER, 2014, 13